Miconazole Nitrate Topical Powder
» Miconazole Nitrate Topical Powder contains not less than 90.0 percent and not more than 110.0 percent of the labeled amount of miconazole nitrate (C18H14Cl4N2O·HNO3).
Packaging and storage—
Preserve in well-closed containers.
USP Reference standards 
11
—
11—
USP Miconazole Nitrate RS 
') + '&img=../../images/v35300/cas-22832-87-7.gif',600,500);)
Identification—
Transfer a portion of Topical Powder, equivalent to about 100 mg of miconazole nitrate to a 50-mL beaker, disperse in 40 mL of methanol, and mix for a minimum of 5 minutes. Allow to settle for 5 to 10 minutes, and filter into a 100-mL beaker. Evaporate on a steam bath to dryness. Dry the residue at 105
for 10 minutes: the IR absorption spectrum of a potassium bromide dispersion of the residue so obtained exhibits maxima only at the same wavelengths as that of a similar preparation of USP Miconazole Nitrate RS.
for 10 minutes: the IR absorption spectrum of a potassium bromide dispersion of the residue so obtained exhibits maxima only at the same wavelengths as that of a similar preparation of USP Miconazole Nitrate RS.
Microbial enumeration tests 61 and Tests for specified microorganisms 62—
The total count does not exceed 100 microorganisms per g, and tests for Staphylococcus aureus, and Pseudomonas aeruginosa, are negative.
61 and Tests for specified microorganisms 62—
The total count does not exceed 100 microorganisms per g, and tests for Staphylococcus aureus, and Pseudomonas aeruginosa, are negative.
Minimum fill 755:
meets the requirements.
755:
meets the requirements.
Assay—
Internal standard solution—
Dissolve cholestane in chloroform to obtain a solution having a concentration of about 0.5 mg per mL.
Standard preparation—
Dissolve an accurately weighed quantity of USP Miconazole Nitrate RS in a mixture of chloroform and methanol (1:1) to obtain a solution having a known concentration of about 0.8 mg per mL. Transfer 5.0 mL of this solution to a test tube, add 2.0 mL of Internal standard solution, and evaporate at a temperature not higher than 40 with the aid of a current of nitrogen to dryness. Dissolve the residue in 2.0 mL of a mixture of chloroform and methanol (1:1), and mix to obtain a Standard preparation having a known miconazole nitrate concentration of about 2 mg per mL.
with the aid of a current of nitrogen to dryness. Dissolve the residue in 2.0 mL of a mixture of chloroform and methanol (1:1), and mix to obtain a Standard preparation having a known miconazole nitrate concentration of about 2 mg per mL.
Assay preparation—
Transfer an accurately weighed portion of Topical Powder, equivalent to about 20 mg of miconazole nitrate, to a stoppered 50-mL centrifuge tube. Add 25.0 mL of methanol, and shake by mechanical means for 30 minutes to dissolve the miconazole nitrate. Centrifuge to obtain a clear supernatant. Transfer 5.0 mL of this solution to a test tube, add 2.0 mL of Internal standard solution, and evaporate at a temperature not higher than 40 with the aid of a current of nitrogen to dryness. Dissolve the residue in 2.0 mL of a mixture of chloroform and methanol (1:1).
with the aid of a current of nitrogen to dryness. Dissolve the residue in 2.0 mL of a mixture of chloroform and methanol (1:1).
Chromatographic system
(see Chromatography 621)—The gas chromatograph is equipped with a flame-ionization detector and a 1.2-m × 2-mm glass column containing 3 percent phase G32 on support S1A. The injection port, detector, and column are maintained at temperatures of about 250, 300, and 250, respectively. Helium is used as the carrier gas, at a flow rate of about 50 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed under Procedure: the resolution, R, between the cholestane and miconazole nitrate peaks is not less than 2.0, and the relative standard deviation for replicate injections is not more than 3.0%.
621)—The gas chromatograph is equipped with a flame-ionization detector and a 1.2-m × 2-mm glass column containing 3 percent phase G32 on support S1A. The injection port, detector, and column are maintained at temperatures of about 250, 300, and 250, respectively. Helium is used as the carrier gas, at a flow rate of about 50 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed under Procedure: the resolution, R, between the cholestane and miconazole nitrate peaks is not less than 2.0, and the relative standard deviation for replicate injections is not more than 3.0%.
Procedure—
Separately inject equal volumes (about 5 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. The relative retention times for cholestane and miconazole nitrate are about 0.5 and 1.0, respectively. Calculate the quantity, in mg, of miconazole nitrate (C18H14Cl4N2O·HNO3) in the portion of Topical Powder taken by the formula:
10C(RU / RS)
in which C is the concentration, in mg per mL, of USP Miconazole Nitrate RS in the Standard preparation, and RU and RS are the peak response ratios of the miconazole nitrate peak to the cholestane peak obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information—
Please check for your question in the FAQs before contacting USP.
| Topic/Question | Contact | Expert Committee |
|---|---|---|
| Monograph | Leonel M. Santos, Ph.D.
Senior Scientific Liaison 1-301-816-8168 |
(SM12010) Monographs - Small Molecules 1 |
| Reference Standards | RS Technical Services 1-301-816-8129 rstech@usp.org |
|
| 61 |
Radhakrishna S Tirumalai, Ph.D.
Principal Scientific Liaison 1-301-816-8339 |
(GCM2010) General Chapters - Microbiology |
| 62 |
Radhakrishna S Tirumalai, Ph.D.
Principal Scientific Liaison 1-301-816-8339 |
(GCM2010) General Chapters - Microbiology |
USP35–NF30 Page 3918